Table 4A.
Category | OptiSafe |
||||||
---|---|---|---|---|---|---|---|
1 | 2 B/A | NC | 2/1 | CNM | Total | ||
in vivo GHS | 1 | 37 | 8 | 0 | 7 | 7 | 59 |
2 B/A | 20 | 14 | 0 | 2 | 1 | 37 | |
NC | 6 | 11 | 30 | 1 | 3 | 51 | |
Total | 63 | 33 | 30 | 10 | 11 | 147 |
Category | OptiSafe |
||||||
---|---|---|---|---|---|---|---|
1 | 2 B/A | NC | 2/1 | CNM | Total | ||
in vivo GHS | 1 | 37 | 8 | 0 | 7 | 7 | 59 |
2 B/A | 20 | 14 | 0 | 2 | 1 | 37 | |
NC | 6 | 11 | 30 | 1 | 3 | 51 | |
Total | 63 | 33 | 30 | 10 | 11 | 147 |